Characterization of deficit schizophrenia and reliability of the bidimensional model of its negative symptomatology

References

• Galderisi S, Mucci A, Buchanan RW, et al. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. 2018;5(8):664–677.
   PubMed Web of Science ®Google Scholar
• Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):14–24.
   PubMed Web of Science ®Google Scholar
• Kaiser S, Heekeren K, Simon JJ. The negative symptoms of schizophrenia: category or continuum? Psychopathology. 2011;44(6):345–353.
   PubMed Web of Science ®Google Scholar
• Gehr J, Glenthøj B, Ødegaard Nielsen M. Validation of the Danish version of the brief negative symptom scale. Nord J Psychiatry. 2019;73(7):425–432.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Mucci A, Galderisi S. Primary, enduring negative symptoms: an update on research. Schizophr Bull. 2017;43(4):730–736.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Fenton WS, Carpenter WT, et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32(2):214–219.
   PubMed Web of Science ®Google Scholar
• Liemburg E, Castelein S, Stewart R, et al. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J Psychiatr Res. 2013;47(6):718–725.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Landi G, Pellegrini C, et al. Negative symptom configuration in first episode Schizophrenia: findings from the “Parma Early Psychosis” program. Nord J Psychiatry. 2019;0:1–8.
   Google Scholar
• Carpenter WT Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145(5):578–583.
   PubMed Web of Science ®Google Scholar
• López-Díaz Á, Lara I, Lahera G. Is the prevalence of the deficit syndrome in schizophrenia higher than estimated? Results of a meta-analysis. Psychiatry Investig. 2018;15(1):94–98.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Buchanan RW, Breier A, et al. Case identification and stability of the deficit syndrome of schizophrenia. 1993;47:47–56.
   Google Scholar
• Goetz RR, Corcoran C, Yale S, et al. Validity of a “proxy” for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS). Schizophr Res. 2007;93(1–3):169–177.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Buchanan RW, McKenny PD, et al. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30(2):119–123.
   PubMed Web of Science ®Google Scholar
• Mucci A, Merlotti E, Üçok A, et al. Primary and persistent negative symptoms: concepts, assessments and neurobiological bases. Schizophr Res. 2017;186:19–28.
   PubMed Web of Science ®Google Scholar
• Kimhy D, Yale S, Goetz RR, et al. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophr Bull. 2006;32(2):274–278.
   PubMed Web of Science ®Google Scholar
• Nakaya M, Ohmori K. A two-factor structure for the schedule for the deficit syndrome in schizophrenia. Psychiatry Res. 2008;158(2):256–259.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Bucci P, Mucci A, et al. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophr Res. 2013;147(1):157–162.
   PubMed Web of Science ®Google Scholar
• Peralta V, Moreno-Izco L, Sanchez-Torres A, et al. Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs. Schizophr Bull. 2014;40(1):214–224.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Galderisi S. Deficit schizophrenia: an update. World Psychiatry. 2008;7(3):143–147.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Buchanan RW, Ross DE, et al. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 2001;58(2):165–171.
   PubMed Web of Science ®Google Scholar
• Bora E, Binnur Akdede B, Alptekin K. Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis. Psychol Med. 2017;47(14):2401–2413.
   PubMed Web of Science ®Google Scholar
• Wheeler AL, Wessa M, Szeszko PR, et al. Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis. JAMA Psychiatry. 2015;72(5):446–455.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Mucci A, Vignapiano A, et al. Electrophysiological aberrations associated with negative symptoms in schizophrenia. Curr Top Behav Neurosci. 2014;21:129–156.
   PubMedGoogle Scholar
• Albayrak Y, Akyol ES, Beyazyüz M, et al. Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2825–2831.
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Haroon E, Miller AH, et al. TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophr Res. 2018;199:281–284.
   PubMed Web of Science ®Google Scholar
• Bobes J. A Spanish validation study of the mini international neuropsychiatric interview. Eur Psychiatry. 1998;13:198–199.
   PubMed Web of Science ®Google Scholar
• Linscott RJ, Allardyce J, Os J. Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr Bull. 2010;36(4):811–829.
   PubMed Web of Science ®Google Scholar
• Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11(9):815–836.
   PubMed Web of Science ®Google Scholar
• Peralta V, Cuesta MJ. Delusional disorder and schizophrenia: a comparative study across multiple domains. Psychol Med. 2016;46(13):2829–2839.
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology. Rockville (MD): U.S. Department of Health, Education, and Welfare; 1976.
   Google Scholar
• Gardner DM, Murphy AL, O’Donnell H, et al. International consensus study of antipsychotic dosing. AJP. 2010;167(6):686–693.
   Google Scholar
• Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64(6):663–667.
   PubMed Web of Science ®Google Scholar
• Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: comparing apples and oranges! Indian J Psychiatry. 2013;55:207.
   PubMed Web of Science ®Google Scholar
• Bernardo M, Fernández-Egea E, Torras A, et al. Adaptation and validation into Spanish of schedule for the deficit syndrome. Med Clin (Barc). 2007;129(3):91–93.
   PubMed Web of Science ®Google Scholar
• Bandalos DL, Finney SJ. Factor analysis: exploratory and confirmatory. In: Reviewer’s guide to Quantitative methods in the social sciences. 2nd ed. New York: Routledge, 2019. Revised edition of the reviewer’s guide to quantitative methods in the social sciences, 2010. New York: Routledge; 2018. p. 98–122.
   Google Scholar
• Arango C, Bobes J, Kirkpatrick B, et al. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. Eur Neuropsychopharmacol. 2011;21(12):867–875.
   PubMed Web of Science ®Google Scholar
• Buchanan RW, Strauss ME, Breier A, et al. Attentional impairments in deficit and nondeficit forms of schizophrenia. Am J Psychiatry. 1997;154(3):363–370.
   PubMed Web of Science ®Google Scholar
• Csukly G, Polgár P, Tombor L, et al. Theory of mind impairments in patients with deficit schizophrenia. Compr Psychiatry. 2014;55(2):349–356.
   PubMed Web of Science ®Google Scholar
• Kösger F, Sahin H, Essizoglu A, et al. Insight and social functioning in deficit and nondeficit schizophrenia. Turk Psikiyatr Derg. 2014;25:157.
   PubMed Web of Science ®Google Scholar
• Tek C, Kirkpatrick B, Buchanan RW. A five-year followup study of deficit and nondeficit schizophrenia. Schizophr Res. 2001;49(3):253–260.
   PubMed Web of Science ®Google Scholar
• Scala S, Lasalvia A, Seidman LJ, et al. Executive functioning and psychopathological profile in relatives of individuals with deficit v. non-deficit schizophrenia: a pilot study. Epidemiol Psychiatr Sci. 2014;23(1):85–97.
   PubMed Web of Science ®Google Scholar
• Tiryaki A, Yazici MK, Anil AE, et al. Reexamination of the characteristics of the deficit schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. 2003;253(5):221–227.
   PubMed Web of Science ®Google Scholar
• Strauss GP, Allen DN, Ross SA, et al. Olfactory hedonic judgment in patients with deficit syndrome schizophrenia. Schizophr Bull. 2010;36(4):860–868.
   PubMed Web of Science ®Google Scholar
• Roy MA, Maziade M, Labbé A, et al. Male gender is associated with deficit schizophrenia: a meta-analysis. Schizophr Res. 2001;47(2-3):141–147.
   PubMed Web of Science ®Google Scholar
• Kopelowicz A, Zarate R, Tripodis K, et al. Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry. 2000;157(6):987–993.
   PubMed Web of Science ®Google Scholar
• Liu J, Cheng M, Shao A, et al. Prevalence and correlated factors of deficit schizophrenia in community-dwelling patients with schizophrenia. Chinese J Behav Med Brain Sci. 2018;27:915–919.
   Google Scholar
• Mayerhoff DI, Loebel AD, Alvir JM, et al. The deficit state in first-episode schizophrenia. Am J Psychiatry. 1994;151(10):1417–1422.
   PubMed Web of Science ®Google Scholar
• Bottlender R, Jäger M, Groll C, et al. Deficit states in schizophrenia and their association with the length of illness and gender. Eur Arch Psychiatry Clin Neurosci. 2001;251(6):272–278.
   PubMed Web of Science ®Google Scholar
• Kanahara N, Sekine Y, Haraguchi T, et al. Orbitofrontal cortex abnormality and deficit schizophrenia. Schizophr Res. 2013;143(2–3):246–252.
   PubMed Web of Science ®Google Scholar
• Mete L, Sarikaya Ö, Erol A. The relationship of deficit syndrome with clinical symptoms, summer births and heritability in patients with schizophrenia. Turk Psikiyatr Derg. 2015;26:3–8.
   Web of Science ®Google Scholar
• Ahmed AO, Strauss GP, Buchanan RW, et al. Schizophrenia heterogeneity revisited: clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups. J Psychiatr Res. 2018;97:8–15.
   PubMed Web of Science ®Google Scholar
• Ludewig K, Vollenweider FX. Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome. Swiss Med Wkly. 2002;132(13–14):159–165.
   PubMed Web of Science ®Google Scholar
• Bobes J, Arango C, Garcia-Garcia M, et al. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: Findings from the CLAMORS study. J Clin Psychiatry. 2010;71, (03):280–286.
   PubMedGoogle Scholar
• Galderisi S, Mucci A, Bitter I, et al. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur Neuropsychopharmacol. 2013;23:196–204.
   PubMed Web of Science ®Google Scholar
• Cohen AS, Brown LA, Minor KS. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis. Schizophr Res. 2010;118(1–3):122–127.
   PubMed Web of Science ®Google Scholar
• Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: Implications for assessment. Schizophr Bull. 2006;32(2):238–245.
   PubMed Web of Science ®Google Scholar
• Strauss GP, Hong LE, Gold JM, et al. Factor structure of the brief negative symptom scale. Schizophr Res. 2012;142(1-3):96–98.
   PubMed Web of Science ®Google Scholar
• Kaiser S, Lyne J, Agartz I, et al. Individual negative symptoms and domains – relevance for assessment, pathomechanisms and treatment. Schizophr Res. 2017;186:39–45.
   PubMed Web of Science ®Google Scholar
• Szendi I, Racsmány M, Cimmer C, et al. Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping. Eur Arch Psychiatry Clin Neurosci. 2010;260(3):257–266.
   PubMed Web of Science ®Google Scholar
• de Winter JCF, Dodou D, Wieringa PA. Exploratory factor analysis with small sample sizes. Multivariate Behav Res. 2009;44:147–181.
   PubMed Web of Science ®Google Scholar
• Amador XF, Kirkpatrick B, Buchanan RW, et al. Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry. 1999;156(4):637–639.
   PubMed Web of Science ®Google Scholar
• Guloksuz S, Van Os J. The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum. Psychol Med. 2018;48(2):229–244.
   PubMed Web of Science ®Google Scholar
• López-Díaz Á, Galiano-Rus S, Herruzo-Rivas A. Differences in the impairment of insight between deficit syndrome and non-deficit syndrome patients with first-episode schizophrenia. Schizophr Res. 2018;193:484–485.
   PubMed Web of Science ®Google Scholar
• López-Díaz Á, Lara I, Lorenzo-Herrero P, et al. Are there differences in the antipsychotic load between deficit and non-deficit syndrome in first-episode schizophrenia? Eur Neuropsychopharmacol. 2017;27:S951–S952
   Web of Science ®Google Scholar
• Reynolds GP. The neurochemistry of schizophrenia. Psychiatry. 2005;4(10):21–25.
   Google Scholar